Product Program year 2019 Source: CMS Open Payments

Luspatercept

Drug

Open in the dashboard

General payments

$353,441

293 payments

Research payments

$2,104,130

53 payments

Through program year 2019, $353,441 in general payments and $2,104,130 in research payments were reported against Luspatercept.

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $353,441 293
2019 Research $2,104,130 53

Breakdown

Who paid General payments · program year 2019
  1. Celgene Corporation $353,441 293 payments
Top recipients General payments · program year 2019
  1. Sujit Sheth Pediatric Hematology-Oncology · New York, NY $24,405 7% · 13 payments
  2. Alexis Thompson Pediatric Hematology-Oncology · Chicago, IL $19,017 5% · 12 payments
  3. Rachelle Nuss Pediatric Hematology-Oncology · Aurora, CO $16,958 5% · 6 payments
  4. Thomas Coates Pediatric Hematology-Oncology · Los Angeles, CA $11,093 3% · 7 payments
  5. Rami Komrokji Hematology · Tampa, FL $10,322 3% · 6 payments

The top 5 of 76 recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Hematology & Oncology Internal Medicine $160,818 46% · 40 practitioners
  2. Pediatric Hematology-Oncology Pediatrics $126,829 36% · 12 practitioners
  3. Medical Oncology Internal Medicine $34,152 10% · 12 practitioners
  4. Hematology Internal Medicine $21,191 6% · 5 practitioners
  5. Internal Medicine $9,121 3% · 2 practitioners

The top 5 of 7 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New York $57,350 16% · 10 recipients
  2. Florida $50,247 14% · 9 recipients
  3. Ohio $39,061 11% · 7 recipients
  4. Maryland $25,089 7% · 9 recipients
  5. Pennsylvania $24,953 7% · 4 recipients

The top 5 of 24 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

293 general · 53 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record